CAS No.:10108-64-2
Name: CADMIUM CHLORIDE
Details Introduction
TOXICITY DATA with REFERENCE:
| 1. |
dni-hmn:hla 250 µmol/L |
MUREAV Mutation Research. 92 (1982),427. | ||
| 2. |
cyt-ofs-mul 630 µg/L/4 W-C |
BECTA6 Bulletin of Environmental Contamination and Toxicology. 36 (1986),199. | ||
| 3. |
orl-wmn LDLo:3 g/kg:BPR,GIT |
BMJOAE British Medical Journal. 292 (1986),1559. | ||
| 4. |
orl-rat LD50:88 mg/kg |
AFDOAQ Association of Food and Drug Officials of the United States, Quarterly Bulletin. 15 (1951),122. | ||
| 5. |
ipr-rat LD50:1800 µg/kg |
EVHPAZ EHP, Environmental Health Perspectives. Subseries of DHEW Publications. 28 (1979),89. | ||
| 6. |
orl-mus LD50:60 mg/kg |
APTOA6 Acta Pharmacologica et Toxicologica. 48 (1981),108. | ||
| 7. |
ihl-mus LC50:2300 mg/m3 |
NTIS** National Technical Information Service. (Springfield, VA 22161) (Formerly U.S. Clearinghouse for Scientific and Technical Information) PB158-508 . | ||
| 8. |
ipr-mus LD50:9300 µg/kg |
NEZAAQ Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. 32 (1977),472. | ||
| 9. |
scu-mus LD50:3200 µg/kg |
APTOA6 Acta Pharmacologica et Toxicologica. 48 (1981),108. | ||
| 10. |
ivn-mus LD50:3500 µg/kg |
Consensus Reports:NTP 10th Report on Carcinogens. IARC Cancer Review: Group 1 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 58 , 1993,p. 119.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 2 , 1973,p. 74.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 11 , 1976,p. 39.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 58 , 1993,p. 119.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; IARC Cancer Review: Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 58 , 1993,p. 119.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; EPA Genetic Toxicology Program. Cadmium and its compounds are on the Community Right-To-Know List. Reported in EPA TSCA Inventory.
SAFETY PROFILE:
The safety information of CADMIUM CHLORIDE(10108-64-2) is as follows:
Hazard Codes:T,T+
,N 
Risk Statements:45-46-60-61-25-26-48/23/25-51/53-50/53-48/20/22-23-22
45:May cause cancer
46:May cause heritable genetic damage
61:May cause harm to the unborn child
25:Toxic if swallowed
26:Very toxic by inhalation
48/23/25:Toxic : danger of serious damage to health by prolonged exposure through inhalation and if swallowed
51/53:Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment
50/53:Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment
48/20/22:Harmful: danger of serious damage to health by prolonged exposure through inhalation and if swallowed
22:Harmful if swallowed
23:Toxic by inhalation
Safety Statements:53-45-61-60-36/37-28
53:Avoid exposure - obtain special instructions before use
45:In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible)
60:This material and its container must be disposed of as hazardous waste
61:Avoid release to the environment. Refer to special instructions/safety data sheets
36/37:Wear suitable protective clothing and gloves
28:After contact with skin, wash immediately with plenty of ... (to be specified by the manufacturer)
RIDADR:UN 3082 9/PG 3
WGK Germany:3
RTECS:EV0175000
F:3-9-23
HazardClass:6.1
PackingGroup:III
Confirmed human carcinogen with experimental carcinogenic and tumorigenic data. Poison by ingestion, inhalation, skin contact, intraperitoneal, subcutaneous, intravenous, and possibly other routes. Human systemic effects by ingestion: blood pressure, acute pulmonary edema, hypermotility, diarrhea. Experimental teratogenic and reproductive effects. Human mutation data reported. Reacts violently with BrF3 and K. When heated to decomposition it emits very toxic fumes of Cd and Cl−. See also CADMIUM COMPOUNDS and CHLORIDES.
Standards and Recommendations:OSHA PEL: TWA 5 μg(Cd)/m3
ACGIH TLV: TWA 0.002 mg(Cd)/m3 (respirable dust), Suspected Human Carcinogen); BEI: 5 μg/g creatinine in urine; 5 μg/L in blood
DFG MAK: Animal Carcinogen, Suspected Human Carcinogen
NIOSH REL: (Cadmium) Reduce to lowest feasible level
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione

